About

Akhilesh Nand joined Biocon, India’s largest biopharmaceuticals company, as vice president and global head of legal in mid-2015. He arrived with almost unparalleled experience in the sector, having helped Ranbaxy Laboratories to complete its $4bn merger with Sun Pharmaceuticals. Nand oversaw all legal work related to the transaction on Ranbaxy’s side, helping to close one of the largest pharmaceuticals mergers ever undertaken in India. He is known as a strong strategic thinker and skilled manager who is capable of raising standards within his team and drawing the best out of his staff. Nand’s wide-ranging experience of the Indian business and legal markets gives him a unique perspective on deal structures and he is credited with playing a leading role in some of India’s most creative M&A transactions. In 2009 he was among those credited with the innovative legal structure behind HCL Technologies’ $1bn acquisition of Axon.